IRIS
BROCCO, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 630
EU - Europa 585
AS - Asia 95
OC - Oceania 3
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.316
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 629
IT - Italia 233
IE - Irlanda 177
SE - Svezia 104
CN - Cina 36
TR - Turchia 20
FR - Francia 17
UA - Ucraina 17
VN - Vietnam 17
DE - Germania 13
IN - India 13
GB - Regno Unito 10
BE - Belgio 6
PK - Pakistan 5
AU - Australia 3
JP - Giappone 2
PT - Portogallo 2
RO - Romania 2
SG - Singapore 2
AR - Argentina 1
AT - Austria 1
CA - Canada 1
ES - Italia 1
EU - Europa 1
FI - Finlandia 1
PL - Polonia 1
SC - Seychelles 1
Totale 1.316
Salva come PNG Salva come JPEG
Città #
Chandler 180
Dublin 172
Chieti 82
Ashburn 57
Jacksonville 48
Princeton 46
Altamura 23
Dong Ket 17
Izmir 17
Wilmington 17
Rome 15
Ann Arbor 13
Lanciano 13
Los Angeles 13
L’Aquila 13
Dearborn 12
New York 11
Beijing 10
Pune 9
Nanjing 8
Norwalk 8
Pescara 8
Houston 7
Washington 7
Brussels 6
Falls Church 6
Oklahoma City 6
Seattle 6
Boardman 5
Islamabad 5
Woodbridge 5
Cambridge 4
Carini 4
Loma Linda 4
Bari 3
Changsha 3
Jiaxing 3
Nanchang 3
Perth 3
Sulmona 3
Ameno 2
Andover 2
Antrodoco 2
Charlotte 2
Edinburgh 2
El Segundo 2
Garden City 2
Grevenbroich 2
Guangzhou 2
Hangzhou 2
London 2
Loreto Aprutino 2
Milan 2
Oxford 2
Pistoia 2
Redlands 2
San Vito Chietino 2
Shanghai 2
Simi Valley 2
Ancona 1
Bologna 1
Buenos Aires 1
Chiaravalle 1
Civitavecchia 1
East Falmouth 1
Elice 1
Fairfield 1
Frankfurt am Main 1
Hanover 1
Hebei 1
Hefei 1
Indianapolis 1
Lisbon 1
Madrid 1
Montesilvano Marina 1
Montreal 1
Mumbai 1
Porto 1
Prato 1
Redwood City 1
Rovigo 1
Rozzano 1
San Mateo 1
San Salvo 1
Shenyang 1
Spoltore 1
Stanford 1
Suzuka 1
Taranto 1
Temecula 1
Treviso 1
Vasto 1
Vienna 1
Vittuone 1
Yokohama 1
Totale 949
Salva come PNG Salva come JPEG
Nome #
Breast cancer "tailored follow-up" in Italian oncology units: A web-based survey 91
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials 77
Exosomes as pleiotropic players in pancreatic cancer 72
Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A “hypothesis-generator” preliminary report 67
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 66
Impact of BMI on clinical outcome in advanced cancer patients treated with anti‑PD‑1 Immune checkpoint inhibitors: a preliminary analysis 66
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation 65
Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study 62
Multicentric retrospective analysis of platinum-pemetrexed regimens as first-line therapy in non-squamous non-small cell lung cancer patients: A “snapshot” from clinical practice 60
Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation" 59
Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study 57
Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: A new algorithm for patient selection and personalized treatment 54
Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression 45
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes 43
Drug repurposing, an attractive strategy in pancreatic cancer treatment: Preclinical and clinical updates 41
Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer 38
Screening of Benzimidazole-Based Anthelmintics and Their Enantiomers as Repurposed Drug Candidates in Cancer Therapy 38
High blood concentration of circulating cancer stem cell-derived extracellular vesicles is associated with poor survival in advanced colorectal cancer patients 38
Whole breast radiotherapy in cN0 early breast cancer patients with pathological sentinel lymph nodes (pN1mic, pN1a) without axillary dissection: preliminary results of the observational LISEN trial 36
Synthesis and evaluation of a large library of nitroxoline derivatives as pancreatic cancer antiproliferative agents 35
Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer 34
Phenotypic and proteomic analysis identifies hallmarks of blood circulating extracellular vesicles in NSCLC responders to immune checkpoint inhibitors 34
The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective 34
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation 31
High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study 24
Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells 24
Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer 23
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 23
Deep polychromatic flow cytometry characterization of circulating endothelial cells in metastatic colorectal cancer patients 22
P1.09 Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation in NSCLC 21
null 21
Prognostic value of gender and primary tumor location in metastatic colon cancer 21
Flow Cytometry Detection of Anthracycline-Treated Breast Cancer Cells: An Optimized Protocol 18
null 14
Novel strategies exploiting interleukin-12 in cancer immunotherapy 14
From cachexia to obesity: the role of host metabolism in cancer immunotherapy 1
Totale 1.469
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.485
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.485
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201920 0 0 0 0 0 0 0 0 0 0 1 19
2019/2020152 32 2 6 4 12 13 16 2 12 16 35 2
2020/2021124 26 0 18 3 5 21 2 4 5 5 3 32
2021/2022179 2 5 8 52 2 25 12 8 11 3 12 39
2022/2023583 38 70 77 52 38 93 29 76 58 5 22 25
2023/2024366 36 5 28 35 13 135 65 17 11 19 2 0
Totale 1.469